Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 3
2002 2
2003 4
2004 1
2005 1
2006 2
2007 1
2008 2
2009 3
2010 4
2011 1
2012 1
2013 2
2014 4
2015 3
2016 3
2017 5
2018 5
2019 3
2020 7
2021 7
2022 4
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Emicizumab state-of-the-art update.
Mahlangu J, Iorio A, Kenet G. Mahlangu J, et al. Among authors: iorio a. Haemophilia. 2022 May;28 Suppl 4(Suppl 4):103-110. doi: 10.1111/hae.14524. Haemophilia. 2022. PMID: 35521723 Free PMC article.
The diversity of emicizumab dosing and pharmacokinetic tools such as the Calibra and the WAPPS-Hemo platforms make it possible to achieve prophylaxis goals in line with the WFH Haemophilia treatment guidelines recommendations, with minimal drug wastage. The emerging experience fr …
The diversity of emicizumab dosing and pharmacokinetic tools such as the Calibra and the WAPPS-Hemo platforms make it possible to achieve pr …
Interventions for enhancing medication adherence.
Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, Agoritsas T, Mistry N, Iorio A, Jack S, Sivaramalingam B, Iserman E, Mustafa RA, Jedraszewski D, Cotoi C, Haynes RB. Nieuwlaat R, et al. Among authors: iorio a. Cochrane Database Syst Rev. 2014 Nov 20;2014(11):CD000011. doi: 10.1002/14651858.CD000011.pub4. Cochrane Database Syst Rev. 2014. PMID: 25412402 Free PMC article. Review.
SELECTION CRITERIA: We included unconfounded RCTs of interventions to improve adherence with prescribed medications, measuring both medication adherence and clinical outcome, with at least 80% follow-up of each group studied and, for long-term treatments, at least six mont …
SELECTION CRITERIA: We included unconfounded RCTs of interventions to improve adherence with prescribed medications, measuring both medicati …
Baker's Cyst with Knee Osteoarthritis: Clinical and Therapeutic Implications.
Abate M, Di Carlo L, Di Iorio A, Salini V. Abate M, et al. Among authors: di iorio a. Med Princ Pract. 2021;30(6):585-591. doi: 10.1159/000518792. Epub 2021 Aug 2. Med Princ Pract. 2021. PMID: 34348320 Free PMC article.
The conservative treatment of both conditions allows significant improvements, but in the medium term (6 months) the efficacy of the therapy declines in patients with knee osteoarthritis associated with Baker's cyst....
The conservative treatment of both conditions allows significant improvements, but in the medium term (6 months) the efficacy of the …
Clinical profile of trazodone users in a multisetting older population: data from the Italian GeroCovid Observational study.
Coin A, Noale M, Gareri P, Trevisan C, Bellio A, Fini F, Abbatecola AM, Del Signore S, Malara A, Mossello E, Fumagalli S, Volpato S, Monzani F, Bellelli G, Zia G, Incalzi RA; GeroCovid Observational Working Group. Coin A, et al. Eur Geriatr Med. 2023 Jun;14(3):465-476. doi: 10.1007/s41999-023-00790-1. Epub 2023 May 19. Eur Geriatr Med. 2023. PMID: 37204681 Free PMC article.
METHODS: This cross-sectional study involved adults aged 60 years at risk of or affected with COVID-19 enrolled in the GeroCovid Observational study from acute wards, geriatric and dementia-specific outpatient clinics, as well as long-term care facilities (LTCF). Participa …
METHODS: This cross-sectional study involved adults aged 60 years at risk of or affected with COVID-19 enrolled in the GeroCovid Observation …
Heart failure patients with improved ejection fraction: Insights from the MECKI score database.
Agostoni P, Pluchinotta FR, Salvioni E, Mapelli M, Galotta A, Bonomi A, Magrì D, Perna E, Paolillo S, Corrà U, Raimondo R, Lagioia R, Badagliacca R, Perrone Filardi P, Apostolo A, Senni M, Iorio A, Correale M, Campodonico J, Palermo P, Cicoira M, Metra M, Guazzi M, Limongelli G, Contini M, Pezzuto B, Sinagra G, Parati G, Cattadori G, Carriere C, Cittar M, Matassini MV, Salzano A, Cittadini A, Masè M, Bandera F, Bussotti M, Mattavelli I, Re F, Vignati C, Lombardi C, Scardovi AB, Sciomer S, Passantino A, Emdin M, Di Lenarda A, Passino C, Santolamazza C, Moscucci F, Zaffalon D, Piepoli M; MECKI Score Research Group. Agostoni P, et al. Among authors: iorio a. Eur J Heart Fail. 2023 Nov;25(11):1976-1984. doi: 10.1002/ejhf.3031. Epub 2023 Oct 3. Eur J Heart Fail. 2023. PMID: 37702313

Cardiovascular mortality rates were 26.6 and 46.9 per 1000 person-years for HFimpEF and pHFrEF, respectively (p < 0.001). Kaplan-Meier analysis showed that HFimpEF had better a long-term prognosis compared with pHFrEF patients. After adjustment for variables differentia

…

Cardiovascular mortality rates were 26.6 and 46.9 per 1000 person-years for HFimpEF and pHFrEF, respectively (p < 0.001). Kaplan-Meier an

…
A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease.
Peyvandi F, Castaman G, Gresele P, De Cristofaro R, Schinco P, Bertomoro A, Morfini M, Gamba G, Barillari G, Jiménez-Yuste V, Königs C, Iorio A, Federici AB. Peyvandi F, et al. Among authors: iorio a. Blood Transfus. 2019 Sep;17(5):391-398. doi: 10.2450/2019.0183-18. Epub 2019 Feb 4. Blood Transfus. 2019. PMID: 30747707 Free PMC article. Clinical Trial.
The aim of the study was to compare efficacy of secondary long-term prophylaxis (PRO) with vWF/FVIII in the prevention of bleeding episodes in severe vWD patients to standard of care (on-demand treatment; ODT). ...
The aim of the study was to compare efficacy of secondary long-term prophylaxis (PRO) with vWF/FVIII in the prevention of bleeding ep …
Tolerance to FVIII: Role of the Immune Metabolic Enzymes Indoleamine 2,3 Dyoxigenase-1 and Heme Oxygenase-1.
Matino D, Afraz S, Zhao G, Tieu P, Gargaro M, Fallarino F, Iorio A. Matino D, et al. Among authors: iorio a. Front Immunol. 2020 Apr 15;11:620. doi: 10.3389/fimmu.2020.00620. eCollection 2020. Front Immunol. 2020. PMID: 32351505 Free PMC article. Review.
., bleeding, infections) although fine tuning of mechanisms of immune tolerance can control this reactivity and promote long-term unresponsiveness to the therapeutically administered factor. ...
., bleeding, infections) although fine tuning of mechanisms of immune tolerance can control this reactivity and promote long-term unr …
Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation.
Paquette M, Mbuagbaw L, Iorio A, Nieuwlaat R. Paquette M, et al. Among authors: iorio a. Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):251-260. doi: 10.1093/ehjcvp/pvaa052. Eur Heart J Cardiovasc Pharmacother. 2021. PMID: 32428195 Free PMC article. Review.
AIMS: Reports of long-term oral anticoagulant (OAC) therapy for atrial fibrillation (AF) reveal highly variable, and generally suboptimal estimates of medication persistence. ...
AIMS: Reports of long-term oral anticoagulant (OAC) therapy for atrial fibrillation (AF) reveal highly variable, and generally subopt …
High rate of spontaneous inhibitor clearance during the long term observation study of a single cohort of 524 haemophilia A patients not undergoing immunotolerance.
Tagariello G, Iorio A, Matino D, Belvini D, Salviato R, Sartori R, Radossi P. Tagariello G, et al. Among authors: iorio a. J Hematol Oncol. 2013 Aug 30;6:63. doi: 10.1186/1756-8722-6-63. J Hematol Oncol. 2013. PMID: 24001010 Free PMC article. Clinical Trial.
METHODS: A retrospective analysis of anti-FVIII inhibitors of long-term registry data in a single centre cohort of 524 haemophilia A patients considered for synovectomy was performed. ...
METHODS: A retrospective analysis of anti-FVIII inhibitors of long-term registry data in a single centre cohort of 524 haemophilia A …
Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia: A review of the literature.
Iorio A, Königs C, Reding MT, Rotellini D, Skinner MW, Mancuso ME, Berntorp E. Iorio A, et al. Haemophilia. 2023 Jan;29(1):33-44. doi: 10.1111/hae.14676. Epub 2022 Oct 12. Haemophilia. 2023. PMID: 36224704 Free PMC article. Review.
AIM: To review literature for clotting factor replacement prophylaxis in people with non-severe haemophilia A and B (HA/HB) in relation to long-term outcomes to support clinical decision-making. METHODS: A targeted literature search was performed to identify studies publis …
AIM: To review literature for clotting factor replacement prophylaxis in people with non-severe haemophilia A and B (HA/HB) in relation to l …
64 results